Cutera International

Cutera International, established in 1998, is a global leader in the development and commercialization of advanced medical aesthetic devices. The company specializes in non-invasive, energy-based technologies that provide safe and effective treatments for dermatologists, plastic surgeons, gynecologists, and other qualified medical professionals. Their offerings include solutions for skin rejuvenation, hair removal, body sculpting, and acne management. The product lineup features multi-application platforms like the Xeo system, which allows for interchangeable handpieces, and innovative devices such as LimeLight for skin rejuvenation, Solera Opus for hair removal, and truSculpt for body sculpting. In 2023, Cutera introduced AviClear, expanding its reach into the acne treatment market. The company serves various sectors, including skincare, healthcare, and cosmetic surgery, with a strong presence in the U.S., Japan, Europe, and Asia. Headquartered in Brisbane, California, Cutera employs around 430 people and reported revenues of approximately $212 million in 2023. The company is dedicated to innovation and efficacy in medical aesthetic technologies, enabling clinicians to provide a wide range of non-invasive treatments.

• Employees 430
• Founded 1998
• Annual Revenue $212369000